Northeast Urology Research

Concord, North Carolina 28025

0 studies enrolling now · 14 studies all time

What they study most

Anemia, Benign Prostatic Hypertrophy, Erectile Dysfunction, Hypogonadism, Nocturia, Prostate Cancer, Prostate Cancer Metastatic, Prostatic Neoplasms, Urinary Incontinence

Studies at this site

• A Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer — Completed
• Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer — Completed
• Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH) — Stopped early
• A Study of Degarelix in Patients With Prostate Cancer — Completed
• Efficacy and Safety of Desmopressin Melt for the Treatment of Nocturia — Completed
• A Trial of Degarelix in Patients With Prostate Cancer — Completed
• The Efficacy and Safety of Degarelix One Month Dosing Regimens in Prostate Cancer — Completed
• Treatment of Anemia in Patients With Cancer Who Are Not Currently Receiving Chemotherapy or Radiotherapy — Stopped early
• Cetrorelix Pamoate IM Regimens in Patients With Symptomatic Benign Prostatic Hyperplasia (BPH) — Completed
• A Comparative Study of Degarelix Three-month Depot in Three Different Dosing Regimens in Patients With Prostate Cancer — Completed
• Efficacy and Safety Evaluating Fispemifene in the Treatment of Hypogonadal Men With Erectile Dysfunction Unresponsive to PDE5 Inhibitors — Completed
• Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate Cancer — Completed
• Using Behavioral Therapy in Combination With Darifenacin for Symptoms of Overactive Bladder — Completed
• The Plenaxis® Experience Study — Paused